No results found.

Screener for Stock Exchange: NASDAQ

Screener Guide [Please Read]
  • This feature is highly experimental—dates are approximate. For exact timings, refer to the chart.
  • Signals include both watch and buy cues; they’re not differentiated here.
  • No buy signal will appear during a green market cycle (we’re risk-averse).
  • Valuations are shown for LSE, NASDAQ, NYSE and TSX only, due to data availability.
  • More green and gold icons indicate higher quality; “?” means inconclusive.
  • Icon order: Quality, Confidence, Operational, Risk Profile.
  • We’re investors (long-term), not traders. Our target is the Demand Threshold Line.
  • Signal prices reflect the week’s open price. It’s best to get close, but small rises aren’t a deal breaker.
  • Cycle shading is approximate: red denotes a risk-averse down phase and green denotes an up phase - refer to the chart for precise position.
  • For optimal timing, “chart hunt”: look for 4+ accumulation signals on a rising momentum line.
  • Use the screener as a guide only.
  • Disclaimer: For informational purposes only. Not financial advice.
Symbol & Metrics Company Name Target Price Model Rating Signal Cycle
Liberty Latin America Ltd. Deeply Overvalued Aug. 1, 2025
Pacific Biosciences of California, Inc. Aug. 1, 2025
Rezolve AI PLC July 28, 2025
The RMR Group Inc. 24.19 Deeply Undervalued July 25, 2025
Sinclair, Inc. Extremely Overvalued July 25, 2025
TORM plc 28.80 Deeply Undervalued July 25, 2025
Cohu, Inc. July 25, 2025
Celldex Therapeutics, Inc. July 25, 2025
Green Plains Inc. 7.00 Fairly Valued July 25, 2025
PENN Entertainment, Inc. 15.32 Moderately Overvalued July 25, 2025
eXp World Holdings, Inc. 6.00 Significantly Overvalued July 25, 2025
PubMatic, Inc. Deeply Overvalued July 25, 2025
Surmodics, Inc. Extremely Overvalued July 25, 2025
Relay Therapeutics, Inc. July 25, 2025
Olaplex Holdings, Inc. Extremely Undervalued July 21, 2025
Definitive Healthcare Corp. 3.61 Moderately Overvalued July 21, 2025
Septerna, Inc. July 21, 2025
Rapport Therapeutics, Inc. July 21, 2025
Hologic, Inc. 56.28 Moderately Overvalued July 18, 2025
Malibu Boats, Inc. Deeply Undervalued July 18, 2025
FormFactor, Inc. 33.40 Significantly Undervalued July 18, 2025
Lands' End, Inc. 11.20 Moderately Overvalued July 18, 2025
Zebra Technologies Corporation 211.43 Significantly Overvalued July 18, 2025
MaxLinear, Inc. July 18, 2025
Opendoor Technologies Inc. July 18, 2025
Service Properties Trust July 18, 2025
Arrowhead Pharmaceuticals, Inc. July 18, 2025
Intellia Therapeutics, Inc. July 18, 2025
Viridian Therapeutics, Inc. July 18, 2025
Bumble Inc. 5.24 Significantly Overvalued July 14, 2025
Upstream Bio, Inc. July 14, 2025
New Providence Acquisition Corp. III July 14, 2025
Harmony Biosciences Holdings, Inc. 36.46 Moderately Undervalued July 11, 2025
PayPal Holdings, Inc. July 11, 2025
Angi Inc. Extremely Undervalued July 11, 2025
Diodes Incorporated 52.60 Moderately Undervalued July 11, 2025
Mill City Ventures III, Ltd. 3.80 Significantly Overvalued July 11, 2025
T. Rowe Price Group, Inc. 71.34 Significantly Overvalued July 11, 2025
SunOpta Inc. 3.03 Significantly Overvalued July 11, 2025
Matthews International Corporation 13.97 Significantly Overvalued July 11, 2025
Cognex Corporation Deeply Overvalued July 11, 2025
Hope Bancorp, Inc. July 11, 2025
GoodRx Holdings, Inc. Extremely Undervalued July 11, 2025
Icahn Enterprises L.P. Extremely Undervalued July 11, 2025
Ingles Markets, Incorporated 91.05 Deeply Undervalued July 11, 2025
Academy Sports and Outdoors, Inc. 66.17 Significantly Undervalued July 11, 2025
Scholastic Corporation 31.59 Significantly Undervalued July 11, 2025
ZoomInfo Technologies Inc. Deeply Overvalued July 11, 2025
Forward Air Corporation Extremely Overvalued July 11, 2025
IDEAYA Biosciences, Inc. July 11, 2025
Loading more…